Dear Shareholders:
Let me begin by acknowledging the countless hours our team has invested developing our business. I have personally spoken at length with our key accounts, strategic partners, employees and investors. Additionally, our team has analyzed a tremendous amount of industry information and collaborated with others outside the company to develop a set of convictions about the future of this business and its value, which I will share in this letter. My goal is to give you our view of the business as it stands today and the challenging, but achievable, work that needs to be done to increase our value to both customers and shareholders. I intend this letter to serve as part of a dialogue with you, our shareholders.
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM
Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM